Submitted by Anonymous (not verified) on 16 September 2024 - 15:16
Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 29, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 29, Status: Authorised